These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18370747)

  • 21. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.
    Watanabe H; Obata H; Watanabe T; Sasaki S; Nagai K; Aizawa Y
    Diabetes Metab Res Rev; 2010 Jan; 26(1):26-32. PubMed ID: 20014332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension.
    Hermida RC; Chayán L; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Jul; 28(6):509-19. PubMed ID: 21797779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor.
    Cerasola G; Cottone S; Mulè G
    J Hypertens; 2010 Dec; 28(12):2357-69. PubMed ID: 20842046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome: time for action.
    Deen D
    Am Fam Physician; 2004 Jun; 69(12):2875-82. PubMed ID: 15222652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies.
    Laguardia HA; Hamm LL; Chen J
    J Nutr Metab; 2012; 2012():652608. PubMed ID: 22523674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome leading to chronic kidney disease: An emerging threat.
    Bandgar TR; Kalra S; Sahay M
    Indian J Endocrinol Metab; 2012 Mar; 16(2):151-3. PubMed ID: 22470847
    [No Abstract]   [Full Text] [Related]  

  • 37. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
    Alberti KG; Eckel RH; Grundy SM; Zimmet PZ; Cleeman JI; Donato KA; Fruchart JC; James WP; Loria CM; Smith SC; ; ; ; ; ;
    Circulation; 2009 Oct; 120(16):1640-5. PubMed ID: 19805654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive definition for metabolic syndrome.
    Huang PL
    Dis Model Mech; 2009; 2(5-6):231-7. PubMed ID: 19407331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D3 mitigates myopathy and metabolic dysfunction in rats with metabolic syndrome: the potential role of dipeptidyl peptidase-4.
    Shoier NO; Ghareib SA; Kothayer H; Alsemeh AE; El-Sayed SS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; ():. PubMed ID: 39356321
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.